The effect of the COVID-19 pandemic on pediatric asthma-related emergency department visits and hospital admissions in Montréal, Quebec: a retrospective cohort study ====================================================================================================================================================================== * Khadidja Chelabi * Esli Osmanlliu * Jocelyn Gravel * Olivier Drouin * Sze Man Tse ## Abstract **Background:** Asthma is a chronic respiratory condition that affects 10% of Canadian children and is often exacerbated by viral respiratory infections, prompting concerns about the severity of SARS-CoV-2 disease in children with asthma. We compared sociodemographic and clinical characteristics of children presenting to the emergency department and the incidence of these visits, before and during the pandemic. **Methods:** We included children aged 0 to 17 years presenting with asthma to 2 tertiary pediatric emergency departments in Montréal, Quebec, between the prepandemic (Jan. 1, 2017, to Mar. 31, 2020) and pandemic (Apr. 1, 2020, to June 30, 2021) periods. We compared the number of emergency department visits and hospital admissions with an interrupted time series analysis and compared the sociodemographic characteristics based on the Canadian Index of Multiple Deprivation (CIMD) and clinical characteristics (including triage level, intensive care admissions, etc.) with Mann–Whitney and χ2 tests. **Results:** We examined 22 746 asthma-related emergency department visits. During the pandemic, a greater proportion of patients presented a triage level 1 or 2 (19.3% v. 14.7%) and were admitted to the intensive care unit (2.5% v. 1.3%). The patients’ CIMD quintile distributions did not differ between the 2 periods. We found a 47% decrease (relative risk [RR] 0.53, 95% confidence interval [CI] 0.37 to 0.76) in emergency department visits and a 49% decrease (RR 0.51, 95% CI 0.34 to 0.76) in hospital admissions during the pandemic. **Interpretation:** The decrease in asthma-related emergency department visits was observed through the third wave of the pandemic, but children presented with a higher acuity and with no identified sociodemographic changes. Future studies are required to understand individual behaviours that may have led to the increased acuity at presentation observed in this study. Asthma is a chronic respiratory condition that affects 10% of Canadian children and is often exacerbated by viral respiratory infections,1 prompting concerns about the severity of COVID-19 in children with asthma. Despite initial concerns that children with asthma would be at risk of severe COVID-19, several studies have since shown that pediatric asthma is not a risk factor for COVID-19 morbidity and death.2–8 Studies in the United States, Japan and Slovenia have reported a decrease in pediatric asthma-related emergency department visits and hospital admissions of 36%–85% during the first wave of the pandemic.9–14 Hypothesized drivers of this decrease include decreased asthma triggers during lockdowns, such as decreased circulation of non–SARS-CoV-2 respiratory viruses and outdoor air pollution.15–18 However, it is unknown if this lower incidence persisted in the months after the first wave, as in-person schooling resumed and some public health measures were lifted. Pediatric asthma exacerbations typically show biannual peaks in the fall (September) and spring, thought to be owing to increased transmission of respiratory viruses and pollen exposure.19,20 Yet, the effect of the pandemic on those peaks has not been studied. Disparities in asthma-related morbidity are well established, with patients from lower socioeconomic status being more severely affected.21,22 The COVID-19 pandemic has magnified many health inequities in children.23–25 However, the studies that reported a decrease in exacerbation during the initial wave of the pandemic did not document whether the pandemic has disparately affected subgroups of Canadian children with asthma (i.e., resulting in increased exacerbations). The identification of a subgroup of children who may be at higher risk for asthma exacerbations during the pandemic may inform policies, for instance, prioritization of vaccination. We analyzed the incidence of asthma-related emergency department visits and hospital admissions by comparing the prepandemic (Jan. 1, 2017, to Mar. 31, 2020) and pandemic periods (Apr. 1, 2020, to June 30, 2021, which encompasses the first 3 waves of the pandemic in Quebec26). In addition, we compared the sociodemographic and clinical characteristics of children presenting to 2 pediatric tertiary care emergency departments for asthma during the prepandemic and pandemic periods, focusing specifically on an area-level index of deprivation and visit acuity at emergency department presentation and hospital admissions. We hypothesized that the decreased incidence of emergency department visits and hospital admissions persisted after the first wave of the pandemic, and is consistent with major public health measures that result in limitation of social contacts. Similarly, we expected that the biannual peaks of asthma would be decreased if not absent. We also hypothesized that children from lower socioeconomic neighbourhoods would be disproportionally represented among asthmarelated emergency department visits during the pandemic, compared with before the pandemic. ## Methods We conducted a retrospective cohort study of the 2 pediatric tertiary care emergency departments in Montréal (Sainte-Justine Hospital University Centre and the Montreal Children’s Hospital). We retrieved data from Jan. 1, 2017, to June 30, 2021. We further defined the prepandemic period between Jan. 1, 2017, and Mar. 31, 2020. The pandemic period was therefore set as Apr. 1, 2020, to June 30, 2021. We chose these dates given the declaration of a public health emergency in Quebec on Mar. 13, 2020, which mandated extensive school and daycare closures and resulted in a presumed decrease in the transmission of respiratory viruses.26 In addition, we assumed a lag time of 2 weeks for public health measures to have an effect on asthma exacerbations. This report follows the Strengthening the Reporting of Observational Studies in Epidemiology Statement.27 ### Participants We included children aged younger than 18 years with an asthma-related emergency department visit, defined as an emergency department visit with a primary discharge diagnosis of asthma or bronchospasm or with an *International Statistical Classification of Diseases and Related Health Problems, 10th Revision, Canada* (ICD-10-CA) code J45 or ICD-9 code 493. These codes are widely used in other asthma studies using administrative data, and both the principal diagnosis and ICD codes have been validated for identifying acute asthma exacerbations. 28 Although not perfect, using ICD codes provides a fair sensitivity and specificity based on a Canadian study.29 In addition, although we acknowledge that a single diagnosis of bronchospasm does not equate to an asthma diagnosis per the Canadian Pediatric Society guidelines,30 we expect an equal effect on the prepandemic and pandemic periods. Children who left the emergency department before being assessed by a physician were excluded from this study as they did not have a discharge diagnosis. ### Data sources We retrieved data from the electronic databases of the 2 participating pediatric emergency departments. Missing variables (i.e., age, sex, length of stay in the emergency department, triage level) were retrieved manually by one of the authors (K.C.) using a standardized study data collection form (form available on request). ### Outcomes and variables Our primary outcome was the monthly number of asthmarelated emergency department visits during the study period, which was further divided into the prepandemic period (Jan. 1, 2017, to Mar. 31, 2020) and the pandemic period (Apr. 1, 2020, to June 30, 2021). Our secondary outcome was the monthly number of asthma-related hospital admissions during the study period. Admission to the intensive care unit (ICU) was defined as an ICU stay at any time during a hospital admission. We evaluated the characteristics related to the emergency department visit or hospital admission, including the length of stay in the emergency department, the length of stay of the hospital admission, if applicable, and the triage level at emergency department presentation. A triage level is assigned to each patient based on the Canadian Paediatric Triage and Acuity Scale31: level 1 (resuscitation), level 2 (emergent), level 3 (urgent), level 4 (less urgent) and level 5 (nonurgent). Whereas most of these data were extracted from the emergency department electronic databases, we complemented the database with a medical chart review when data were missing for selected patients and variables. Patient-related characteristics that were collected included age, sex and the patients’ 6-character postal code, which was used to derive the Canadian Index of Multiple Deprivation (CIMD).32 The CIMD is an index of deprivation and marginalization and provides a quintile based on the subject’s postal code for each of the 4 dimensions of deprivation (residential instability, economic dependency, ethnocultural composition, situational vulnerability). It allows the comparison of measures of social well-being between an individuals’ residency area. For each of the 4 dimensions, the first quintile represents the least deprived and the fifth quintile represents the most deprived. To derive the CIMD, the individual’s residential 6-character postal code was converted through the Postal Code Conversion File33 and then mapped to the CIMD. ### Statistical analysis We performed a descriptive analysis of the weekly number of asthma-related emergency department visits and hospital admissions and conducted an uncontrolled interrupted time series analysis to analyze the effect of the pandemic on asthmarelated emergency department visits. Specifically, we compared the monthly number of asthma-related emergency department visits between the prepandemic period and the pandemic period, assuming a level change model and a quasi-Poisson distribution. Furthermore, analyses were adjusted for seasonality through a Fourier term.34 In a sensitivity analysis, we compared the number of asthma-related emergency department visits in the second and third wave of the pandemic to the prepandemic period by excluding the first wave (April–July 2021) in the analysis to show the variable effect of the pandemic through the different waves. Given the distinctive asthma phenotypes between preschool- and school-aged children, we also conducted an analysis stratified by age (≤ 5 yr v. ≥ 6 yr). We performed a similar analysis for asthma-related hospital admissions. We described and compared the visit- and patient-related characteristics using the Mann–Whitney test for continuous data and calculated the differences in proportions for variables with 2 or fewer categories. The 95% confidence intervals (CIs) for differences in medians and proportions are presented for these analyses. We used the χ2 goodness-of-fit test to compare the distribution of variables with more than 2 categories (statistical significance was set at *p* < 0.05). Analyses were performed with R software version 4.0.5 ([www.r-project.org](http://www.r-project.org), packages lmtest and splines). ### Ethics approval The institutional research ethic boards of the Sainte-Justine Hospital University Centre (no. 21-2021-3292) and the Montreal Children’s Hospital (no. 21-2021-7573) approved this study and waived the need for participant consent. ## Results Between Jan. 1, 2017, and June 30, 2021, there were 22 746 asthma-related emergency department visits between the 2 centres, with 19 408 during the prepandemic period and 3338 during the pandemic. Missing variables (*n* < 150 entries) were retrieved manually. The median age of these children was 2.7 (interquartile range [IQR] 1.7 to 5.0) years and 14 256 (62.7%) were male (Table 1). Most children came from neighbourhoods with high residential instability and more diverse ethnocultural composition (Figure 1 and Appendix 1, available at [www.cmajopen.ca/content/11/1/E152/suppl/DC1](http://www.cmajopen.ca/content/11/1/E152/suppl/DC1)) and presented with a triage level 3 (*n* = 15 990, 70.3%), representing a serious but non-life-threatening health problem. Throughout the study period, 1939 (8.5%) children presenting to the emergency department for asthma were admitted to the hospital, with 334 (17.3%) requiring admission to the ICU. View this table: [Table 1:](http://www.cmajopen.ca/content/11/1/E152/T1) Table 1: Sociodemographic and clinical characteristics of patients presenting to the emergency department for an asthma-related visit for the study period and comparing the prepandemic and pandemic periods ![Figure 1:](http://www.cmajopen.ca/https://www.cmajopen.ca/content/cmajo/11/1/E152/F1.medium.gif) [Figure 1:](http://www.cmajopen.ca/content/11/1/E152/F1) Figure 1: Comparison of the CIMD during the prepandemic and pandemic periods. The distribution of the 4 dimensions of the CIMD did not significantly differ between the prepandemic and the pandemic periods. Note: CIMD = Canadian Index of Multiple Deprivation, Q1 = quintile 1, Q2 = quintile 2, Q3 = quintile 3, Q4 = quintile 4, Q5 = quintile 5. ### Asthma-related emergency department visits and hospital admissions The observed yearly trends for asthma-related emergency department visits between Jan. 1, 2017, and Mar. 31, 2020, were similar, with biannual peaks in the fall and spring and a decrease in visits from June to August (Figure 2A). Adjusting for seasonality, there was a 47% decrease (relative risk [RR] 0.53, 95% CI 0.37 to 0.76) in the number of asthma-related emergency department visits during the pandemic period compared with the prepandemic period. Two nadirs in emergency department visits were identified, the first from April to June 2020, and the second in January 2021. Whereas the typical peak of asthma emergency department visits in September was nonetheless observed during the pandemic, it is attenuated compared with the peaks from 2017 to 2019 (448 visits in September 2020 v. an average of 637 visits in September from 2017 to 2019). Although asthma-related emergency department visits usually decrease after May and throughout the summer, we observed an increasing trend in emergency department visits through June 2021, with an average increase of 87 visits per month for the period of January to June 2021. In comparison, for the same period during 2017 to 2019, an average decrease of 19 visits per month was observed. The decrease in emergency department visits remained significant when we focused only on the second and third wave of the pandemic, with a 35% decrease (RR 0.65, 95% CI 0.48 to 0.87) compared with the prepandemic period. Among children aged 5 years or younger and those 6 years or older, there was a 49% decrease (RR 0.51, 95% CI 0.34 to 0.74) and a 38% decrease (RR 0.62, 95% CI 0.45 to 0.87) in the number of asthma-related emergency department visits during the pandemic, respectively. ![Figure 2:](http://www.cmajopen.ca/https://www.cmajopen.ca/content/cmajo/11/1/E152/F2.medium.gif) [Figure 2:](http://www.cmajopen.ca/content/11/1/E152/F2) Figure 2: Weekly incidence of asthma-related emergency department visits (A) and of asthma-related hospital admissions (B) during the COVID-19 pandemic (solid line) compared with the average of 2017–2019 (dotted line). (A) Closure of primary schools and high schools (Mar. 13 to Sept. 1, 2020). (B) Opening of daycare services (June 1, 2020). (C) Closure of primary schools and high schools (Dec. 20, 2020, to Jan. 18, 2021) and implementation of mandatory procedural masking at all times in high schools. (D) Procedural masking in primary schools (at all times for grades 5 and 6 and in shared spaces for grades 1–4) (Jan. 11, 2021). (E) Procedural masking in primary schools at all times for grades 1–6 (Mar. 8, 2021). (F) Start of relaxation of public health measures relaxation in Quebec (May 28, 2021). Similar trends were observed for asthma-related hospital admissions (Figure 2B). Adjusting for seasonality, there was a 49% decrease (RR 0.51, 95% CI 0.34 to 0.76) in the number of asthma-related hospital admissions during the pandemic period, compared with the prepandemic period (Appendix 2, available at [www.cmajopen.ca/content/11/1/E152/suppl/DC1](http://www.cmajopen.ca/content/11/1/E152/suppl/DC1)). An increasing trend in hospital admissions through June 2021 was also observed, with an average increase of 8 hospital admissions per month for the period of January to June 2021. In comparison, for the same period during 2017 to 2019, an average decrease of 3 hospital admissions per month was observed. The decrease in hospital admissions remained significant when we focused on the second and third wave of the pandemic, with a 39% decrease (RR 0.61, 95% CI 0.43 to 0.86) compared with the prepandemic period. Among children aged 5 years or younger, there was a 48% decrease (RR 0.52, 95% CI 0.35 to 0.78) in the number of asthma-related hospital admissions during the pandemic. The change was not significant among children aged 6 years or older (33% decrease, RR 0.67, 95% CI 0.42 to 1.10), although the total number of hospital admissions among this age group was small (389 hospital admissions throughout the study period, with only 75 during the pandemic). ### Clinical and patient characteristics before and during the pandemic There was no difference in the proportion of children requiring hospital admission between the pandemic and the prepandemic periods (difference in proportions of −0.4%, 95% CI −0.6% to 1.4%). A higher proportion of children were admitted to the ICU during the pandemic (*n* = 84, 2.5% pandemic v. *n* = 253, 1.3% prepandemic of all children presenting to the emergency department or 29.7% pandemic v. 15.2% prepandemic of all children who were admitted to the hospital). The median length of stay in the emergency department was only slightly lower during the pandemic (0.1 h) and is likely clinically insignificant. Compared with the prepandemic period, a slightly higher proportion of males presented to the emergency department during the pandemic period (difference in proportions of 2.7%, 95% CI 1.0% to 4.5%). There was no difference in the CIMD quintile distributions of children presenting before and during the pandemic (Figure 1). A higher proportion of children presented with triage level 1–2 (condition requiring immediate or rapid intervention) during the pandemic (*n* = 658, 19.7% pandemic v. *n* = 2855, 14.7% prepandemic, 95% CI for difference in proportions 3.5% to 6.5%). ## Interpretation We documented an overall 47% decrease in asthma-related emergency department visits and a 49% decrease in asthmarelated hospital admissions through the third wave of the pandemic compared with the prepandemic period. This decrease was most notable during the initial months of the pandemic and in January 2021, although a steep increase in the number of asthma-related emergency department visits and hospital admissions was observed from January to June 2021. Asthma-related visits during the pandemic were characterized by more severe clinical acuity and a higher proportion of ICU hospital admissions. The distribution of the index of deprivation among children presenting to the emergency department for asthma did not differ between the prepandemic and pandemic periods, suggesting that prepandemic sociodemographic inequalities did not widen during the pandemic. The decrease in asthma-related emergency department visits and hospital admissions during the pandemic may be explained by several factors. Public health measures likely led to a decreased transmission of other respiratory viruses, a common trigger of asthma exacerbations. Indeed, data from the Respiratory Virus Detection Surveillance System15 showed a decrease in the percentage of positive tests for 7 common respiratory viruses in September 2020 compared with prepandemic years for Canada and Quebec. Furthermore, decreased exposures to air pollution, a trigger of asthma exacerbations, may have contributed to the decrease in adverse asthma events. In fact, the city of Montréal reported a 10% improvement in air quality from March to April 2020 compared with the same period in 2017–2019 with important decreases in particulate matter 2.5 and nitrogen dioxide levels,16,17 corroborating observations around the world.10,18 Finally, families may have an increased threshold for medical consultations during the pandemic and there may have been an increased adherence to asthma controller medication.35 This may be triggered by the fear associated with the potential effect of COVID-19 on children with asthma and a study suggesting that inhaled corticosteroids was associated with reduced angiotensin-converting enzyme 2 messenger RNA expression, the receptor of SARS-CoV-2,36,37 although this association remains controversial.38 We observed an increasing trend in the incidence of asthma-related emergency department visits following the nadir in January 2021, culminating with the highest incidence in June 2021 at the end of our study period. Typically, before the pandemic, asthma exacerbations start to decrease in June through the summer months. Interestingly, this surge of asthma exacerbations follows the general relaxation of public health measures in Quebec (reopening of restaurants, indoor and outdoor gatherings allowed) at the end of May 2021 and removal of mandatory masking in school in May 2021. This also coincides with an increase in the number of positive tests for common respiratory viruses in Quebec, particularly for respiratory syncytial virus and parainfluenza.15 Thus, we hypothesize that the relaxation of public health measures led to increased transmission of common respiratory viruses, which in turn led to increased asthma exacerbations. Since the effect on asthma-related emergency department visits and hospital admissions is likely multifactorial, we chose not to analyze the effect of individual public health measures on the outcome. However, we identified the timing of the implementation and lifting of key public health measures pertaining to children based on the COVID-19 timeline in Quebec and denoted the dates in Figure 2.26 We observed that changes in the trends in asthma-related emergency department visits and hospital admissions were related to the implementation and lifting of public health measures, particularly those affecting daycares and schools. The drastic decrease in asthma-related emergency department visits and hospital admissions observed between April and June 2020 follows school and daycare closures on Mar. 13, 2020, and a generalized lockdown on Mar. 24, 2020, in Quebec. Subsequently, in July 2020, the weekly incidence of emergency department visits rapidly increased to numbers similar to those seen in 2017–2019. This follows the reopening of daycares in June 2020, and the reopening of restaurants, businesses and gatherings in early July 2020. Quebec schools subsequently reopened for full or partial in-person attendance as of August to September 2020. Interestingly, even during the pandemic, we observed the typical annual peak in asthma-related emergency department visits in September 2020. However, this peak was attenuated compared with the same period prepandemic. Of note, a partial return to school (50% in person) was instituted for children in grades 10 and 11, and mandatory masking in schools was implemented for all children 12 years and older. The second nadir in asthma-related emergency department visits and hospital admissions in January 2021 follows a prolonged closure of primary and secondary schools for the holidays. Although the effect of individual measures is hardly quantifiable, we note a temporal association between pandemic-related public health measures and the incidence of asthma exacerbations. Whereas some of these measures, such as school closures, would not be implementable outside of the pandemic context, other measures such as masking to prevent viral transmission could be considered as a public health strategy for asthma management. Whereas characteristics of children presenting to the emergency department for asthma were relatively unchanged during the pandemic, we found that children presented with a higher level of acuity and a greater percentage were admitted to the ICU despite an unchanged rate of hospital admissions. The higher presenting acuity was also observed for all-cause emergency department visits.35 Decreased in-person outpatient visits, the temporary suspension of pulmonary function testing and increased parental thresholds for medical consultations, which may all lead to poorer acute and chronic management of asthma, may have contributed to the increased acuity in presentation.35 During the pandemic, children who presented to the emergency department were slightly older (median age of 3.1 yr v. 2.6 yr prepandemic, 95% CI for the difference 0.3 to 0.7 yr). In our analyses stratified by age, we also observed a larger decrease in asthma-related emergency department visits and hospital admissions among children 5 years or younger. For preschool-aged children, respiratory viruses are the main triggers for asthma exacerbations, and viral respiratory illnesses overall have drastically decreased during the pandemic. Although we do not have school or daycare attendance data, it is possible that while school attendance was mandatory as of September 2020 in Quebec, a higher number of preschool-aged children may have been kept home from daycares, further decreasing their exposure to respiratory viruses. Given these factors, we hypothesize that the pandemic has disproportionately reduced the risk of asthma exacerbations in younger children, which could explain the older age of children presenting to the emergency department during the pandemic. Based on the multidimensional CIMD, children presenting to the emergency department for asthma prepandemic were not different from those presenting during the pandemic. Whereas previous studies did not examine the disparities in the incidence of asthma exacerbations during the pandemic in children with lower socioeconomic status or in minority groups, studies have reported higher COVID-19–related morbidity in minorities.23–25,39–41 Suggested mechanisms for these inequalities included differential access to care, increased viral exposure and lower income, which may put these subgroups of children at higher risk of adverse health outcomes.41 Our findings suggest that the pandemic did not widen existing disparity in children from more deprived neighbourhoods in Montréal with regard to asthma-related emergency department visits and hospital admissions compared with the prepandemic period. ### Limitations Our study has noteworthy limitations. First, owing to the retrospective nature of our study, we did not have data on other potential confounding variables such as medication adherence or other patient-level data such as comorbidities. We also did not have environmental data to control for variations in outdoor allergens, another trigger of asthma exacerbations, although the effect of this trigger is modest at the population level.42 Second, although we did not have individual-level data on the race or ethnicity of the patient, the CIMD captures multiple dimensions of deprivation at a granular level. In fact, its calculation is based on the 6-digit postal code, and in Quebec, there is on average 39 residents per postal code. Third, our data were restricted to 2 pediatric tertiary care centres in Montréal, Quebec. Although the catchment area of our 2 centres is large, our findings may not be generalizable to children living in nonurban settings or other regions of Quebec and Canada, particularly given region- and province-specific public health measures during the pandemic. Fourth, children who left the emergency department before being assessed by a physician were excluded from this study as they did not have a discharge diagnosis. Finally, although there are national guidelines for the diagnosis of asthma,30,43 including in preschoolers, misclassification is possible (e.g., a first episode of wheeze that was labelled as asthma). However, this misclassification would have affected the prepandemic and pandemic data equally. ### Conclusion We did not find a difference in the existing overrepresentation of children from more deprived neighbourhoods presenting with asthma exacerbations during the pandemic. We observed a decrease (about 50%) in pediatric asthma-related emergency department visits and hospital admissions over the first 15 months of the pandemic, although the incidence varies with the implementation and relaxation of public health measures. Whereas some measures are exceptional (e.g., school closures), others may be more easily implemented and socially acceptable after the pandemic, such as masking in public spaces when one is symptomatic to limit the transmission of respiratory viruses. This in turn could lead to decreased asthma exacerbations. Further studies should focus on individual behaviours and how these affect the risk of asthma exacerbations. ## Acknowledgement The authors thank Kevin Jutras for his help with data extraction. ## Footnotes * **Competing interests:** None declared. * This article has been peer reviewed. * **Contributors:** Khadidja Chelabi, Esli Osmanlliu, Jocelyn Gravel, Olivier Drouin and Sze Man Tse contributed to the conception and design of the work. Khadidja Chelabi and Sze Man Tse contributed to the acquisition and analysis of the data. Khadidja Chelabi drafted the manuscript. All authors interpreted the data, revised the manuscript critically for important intellectual content, gave final approval of the version to be published and agreed to be accountable for all aspects of the work. * **Funding:** Olivier Drouin and Sze Man Tse are supported by a clinician research scholar–junior 1 award from the Fonds de recherche du Quebec – Santé. * **Data sharing:** No data from this project are shared. Only the primary investigators have access to data. * **Supplemental information:** For reviewer comments and the original submission of this manuscript, please see [www.cmajopen.ca/content/11/1/E152/suppl/DC1](http://www.cmajopen.ca/content/11/1/E152/suppl/DC1). This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: [https://creativecommons.org/licenses/by-nc-nd/4.0/](https://creativecommons.org/licenses/by-nc-nd/4.0/) ## References 1. (2021) Managing an acute asthma exacerbation in children [position statement] (Canadian Pediatric Society, Ottawa) Available: [https://cps.ca/en/documents//position//managing-an-acute-asthma-exacerbation/](https://cps.ca/en/documents//position//managing-an-acute-asthma-exacerbation/). accessed 2022 July 28. 2. Abrams EM, Sinha I, Fernandes RM, et al. (2020) Pediatric asthma and COVID-19: the known, the unknown, and the controversial. Pediatr Pulmonol 55:3573–8. 3. Castro-Rodriguez JA, Forno E (2020) Asthma and COVID-19 in children: a systematic review and call for data. Pediatr Pulmonol 55:2412–8. [PubMed](http://www.cmajopen.ca/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fcmajo%2F11%2F1%2FE152.atom) 4. Chao JY, Derespina KR, Herold BC, et al. (2020) Clinical characteristics and outcomes of hospitalized and critically ill children and adolescents with coronavirus disease 2019 at a tertiary care medical center in New York City. J Pediatr 223:14–9e2. [CrossRef](http://www.cmajopen.ca/lookup/external-ref?access_num=10.1016/j.jpeds.2020.05.006&link_type=DOI) [PubMed](http://www.cmajopen.ca/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fcmajo%2F11%2F1%2FE152.atom) 5. Ciprandi G, Licari A, Filippelli G, et al. (2020) Children and adolescents with allergy and/or asthma seem to be protected from coronavirus disease 2019. Ann Allergy Asthma Immunol 125:361–2. 6. Du H, Dong X, Zhang J-J, et al. (2021) Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status. Allergy 76:510–32. [PubMed](http://www.cmajopen.ca/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fcmajo%2F11%2F1%2FE152.atom) 7. Wang J-Y, Pawankar R, Tsai H-J, et al. (2021) COVID-19 and asthma, the good or the bad? Allergy 76:565–7. 8. Chhiba KD, Patel GB, Vu THT, et al. (2020) Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19. J Allergy Clin Immunol 146:307–14e4. [PubMed](http://www.cmajopen.ca/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fcmajo%2F11%2F1%2FE152.atom) 9. Kenyon CC, Hill DA, Henrickson SE, et al. (2020) Initial effects of the COVID-19 pandemic on pediatric asthma emergency department utilization. J Allergy Clin Immunol Pract 8:2774–76e1. [PubMed](http://www.cmajopen.ca/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fcmajo%2F11%2F1%2FE152.atom) 10. Taquechel K, Diwadkar AR, Sayed S, et al. (2020) Pediatric asthma health care utilization, viral testing, and air pollution changes during the COVID-19 pandemic. J Allergy Clin Immunol Pract 8:3378–87e11. [PubMed](http://www.cmajopen.ca/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fcmajo%2F11%2F1%2FE152.atom) 11. Oreskovic NM, Kinane TB, Aryee E, et al. (2020) The unexpected risks of COVID-19 on asthma control in children. J Allergy Clin Immunol Pract 8:2489–91. 12. Krivec U, Kofol Seliger A, Tursic J (2020) COVID-19 lockdown dropped the rate of paediatric asthma admissions. Arch Dis Child 105:809–10. [FREE Full Text](http://www.cmajopen.ca/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiRlVMTCI7czoxMToiam91cm5hbENvZGUiO3M6MTI6ImFyY2hkaXNjaGlsZCI7czo1OiJyZXNpZCI7czo5OiIxMDUvOC84MDkiO3M6NDoiYXRvbSI7czoyMToiL2NtYWpvLzExLzEvRTE1Mi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 13. Simoneau T, Greco KF, Hammond A, et al. (2021) Impact of the COVID-19 pandemic on pediatric emergency department use for asthma. Ann Am Thorac Soc 18:717–9. 14. Bun S, Kishimoto K, Shin J-H, et al. (2021) Impact of the COVID-19 pandemic on asthma exacerbations in children: a multi-center survey using an administrative database in Japan. Allergol Int 70:489–91. 15. (July 31, 2021) Respiratory virus report, week 30: ending (Public Health Agency of Canada, Ottawa) modified 2021 Aug. 5. Available: [https://www.canada.ca/en/public-health/services/surveillance/respiratory-virus-detections-canada/2021-2022/week-30-ending-july-31-2021.html](https://www.canada.ca/en/public-health/services/surveillance/respiratory-virus-detections-canada/2021-2022/week-30-ending-july-31-2021.html). accessed 2021 Aug. 22. 16. Flash info 2020 impact du confinement sur la qualité de l’air de l’agglomération de Montréal (Montréal: Service de l’environnement, Ville de Montréal) Available: [https://portail-m4s.s3.montreal.ca/pdf/impact\_confinement\_qualite\_air.pdf](https://portail-m4s.s3.montreal.ca/pdf/impact_confinement_qualite_air.pdf). accessed 2021 Aug. 4. 17. Environmental Assessment Report 2020 air quality in Montréal (Montréal: Service de l’environnement, Ville de Montréal) Available: [https://portail-m4s.s3.montreal.ca/pdf/26849\_bilan\_qualite\_air\_2020\_ang\_lr-2.pdf](https://portail-m4s.s3.montreal.ca/pdf/26849\_bilan\_qualite\_air_2020_ang_lr-2.pdf). accessed 2021 Aug. 4. 18. Chauhan A, Singh RP (2020) Decline in PM2.5 concentrations over major cities around the world associated with COVID-19. Environ Res 187:109634. [CrossRef](http://www.cmajopen.ca/lookup/external-ref?access_num=10.1016/j.envres.2020.109634&link_type=DOI) 19. Larsen K, Zhu J, Feldman LY, et al. (2016) The annual September peak in asthma exacerbation rates. Still a reality? Ann Am Thorac Soc 13:231–9. [PubMed](http://www.cmajopen.ca/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fcmajo%2F11%2F1%2FE152.atom) 20. Cohen HA, Blau H, Hoshen M, et al. (2014) Seasonality of asthma: a retrospective population study. Pediatrics 133:e923–32. [CrossRef](http://www.cmajopen.ca/lookup/external-ref?access_num=10.1542/peds.2013-2022&link_type=DOI) [PubMed](http://www.cmajopen.ca/lookup/external-ref?access_num=24616356&link_type=MED&atom=%2Fcmajo%2F11%2F1%2FE152.atom) 21. To T, Dell S, Tassoudji M, et al. (2009) Health outcomes in low-income children with current asthma in Canada. Chronic Dis Can 29:49–55. [PubMed](http://www.cmajopen.ca/lookup/external-ref?access_num=19281690&link_type=MED&atom=%2Fcmajo%2F11%2F1%2FE152.atom) 22. Cope SF, Ungar WJ, Glazier RH (2008) Socioeconomic factors and asthma control in children. Pediatr Pulmonol 43:745–52. [CrossRef](http://www.cmajopen.ca/lookup/external-ref?access_num=10.1002/ppul.20847&link_type=DOI) [PubMed](http://www.cmajopen.ca/lookup/external-ref?access_num=18615669&link_type=MED&atom=%2Fcmajo%2F11%2F1%2FE152.atom) [Web of Science](http://www.cmajopen.ca/lookup/external-ref?access_num=000258590300003&link_type=ISI) 23. Havers FP, Whitaker M, Self JL, et al., COVID-NET Surveillance Team (2021) Hospitalization of adolescents aged 12–17 years with laboratory-confirmed COVID-19 — COVID-NET, 14 States, March 1, 2020–April 24, 2021. MMWR Morb Mortal Wkly Rep 70:851–7. [PubMed](http://www.cmajopen.ca/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fcmajo%2F11%2F1%2FE152.atom) 24. Saatci D, Ranger TA, Garriga C, et al. (2021) Association between race and COVID-19 outcomes among 2.6 million children in England. JAMA Pediatr 175:928–38. 25. Kyeremateng R, Oguda L, Asemota O, International Society for Social Pediatrics and Child Health (ISSOP) COVID-19 Working Group (2022) COVID-19 pandemic: health inequities in children and youth. Arch Dis Child 107:297–9. [FREE Full Text](http://www.cmajopen.ca/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiRlVMTCI7czoxMToiam91cm5hbENvZGUiO3M6MTI6ImFyY2hkaXNjaGlsZCI7czo1OiJyZXNpZCI7czo5OiIxMDcvMy8yOTciO3M6NDoiYXRvbSI7czoyMToiL2NtYWpvLzExLzEvRTE1Mi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 26. Ligne du temps COVID-19 au Québec (Institut national de santé publique du Québec, Québec) updated 2022 Aug. 8. Available: [https://www.inspq.qc.ca/covid-19/donnees/ligne-du-temps](https://www.inspq.qc.ca/covid-19/donnees/ligne-du-temps). accessed 2021 Aug. 21. 27. (2021) STROBE: strengthening the reporting of observational studies in epidemiology (University of Bern, Bern (Switzerland)) Available: [https://www.strobe-statement.org/](https://www.strobe-statement.org/). accessed 2022 July 29. 28. Sundaresan AS, Schneider G, Reynolds J, et al. (2018) Identifying asthma exacerbation-related emergency department visit using electronic medical record and claims data. Appl Clin Inform 9:528–40. 29. Xi N, Wallace R, Agarwal G, et al. (2015) Identifying patients with asthma in primary care electronic medical record systems. Can Fam Physician 61:e474–83. [Abstract/FREE Full Text](http://www.cmajopen.ca/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiY2ZwIjtzOjU6InJlc2lkIjtzOjEwOiI2MS8xMC9lNDc0IjtzOjQ6ImF0b20iO3M6MjE6Ii9jbWFqby8xMS8xL0UxNTIuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 30. (2015) Diagnosis and management of asthma in preschoolers: a Canadian Thoracic Society and Canadian Paediatric Society position paper [position statement] (Canadian Paediatric Society), Available: [https://cps.ca/en/documents//position//asthma-in-preschoolers/](https://cps.ca/en/documents//position//asthma-in-preschoolers/). accessed 2022 Mar. 12. 31. Bullard MJ, Musgrave E, Warren D, et al. (2017) Revisions to the Canadian Emergency Department Triage and Acuity Scale (CTAS) guidelines 2016. CJEM 19(Suppl 2):S18–27. [PubMed](http://www.cmajopen.ca/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fcmajo%2F11%2F1%2FE152.atom) 32. (2019) Canadian Index of Multiple Deprivation: user guide. Cat no 45-20-0001 (Statistics Canada, Ottawa) Available[https://www150.statcan.gc.ca/n1/pub/45-20-0001/452000012019002-eng.htm](https://www150.statcan.gc.ca/n1/pub/45-20-0001/452000012019002-eng.htm). accessed 2021 Aug. 21. 33. Postal CodeOM Conversion File (Statistics Canada, Ottawa) Available[https://www150.statcan.gc.ca/n1/en/catalogue/92-154-X](https://www150.statcan.gc.ca/n1/en/catalogue/92-154-X). accessed 2021 Aug. 21. 34. Bernal JL, Cummins S, Gasparrini A (2017) Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol 46:348–55. [CrossRef](http://www.cmajopen.ca/lookup/external-ref?access_num=10.1093/ije/dyw098&link_type=DOI) [PubMed](http://www.cmajopen.ca/lookup/external-ref?access_num=27283160&link_type=MED&atom=%2Fcmajo%2F11%2F1%2FE152.atom) 35. Fontaine P, Osmanlliu E, Gravel J, et al. (Apr 7, 2021) Impact of COVID-19 on pediatric emergency department visits: a retrospective cohort study. medRxiv doi:10.1101/2021.04.05.21254921. [Abstract/FREE Full Text](http://www.cmajopen.ca/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoibWVkcnhpdiI7czo1OiJyZXNpZCI7czoyMToiMjAyMS4wNC4wNS4yMTI1NDkyMXYxIjtzOjQ6ImF0b20iO3M6MjE6Ii9jbWFqby8xMS8xL0UxNTIuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 36. Peters MC, Sajuthi S, Deford P, et al. (2020) COVID-19-related genes in sputum cells in asthma. Relationship to demographic features and corticosteroids. Am J Respir Crit Care Med 202:83–90. [PubMed](http://www.cmajopen.ca/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fcmajo%2F11%2F1%2FE152.atom) 37. Maes T, Bracke K, Brusselle GG (2020) COVID-19, asthma, and inhaled corticosteroids: another beneficial effect of inhaled corticosteroids? Am J Respir Crit Care Med 202:8–10. [CrossRef](http://www.cmajopen.ca/lookup/external-ref?access_num=10.1164/rccm.202005-1651ED&link_type=DOI) 38. O’Beirne SL, Salit J, Kaner RJ, et al. (2021) Up-regulation of ACE2, the SARS-CoV-2 receptor, in asthmatics on maintenance inhaled corticosteroids. Respir Res 22:200. 39. Gross CP, Essien UR, Pasha S, et al. (2020) Racial and ethnic disparities in population-level COVID-19 mortality. J Gen Intern Med 35:3097–9. [PubMed](http://www.cmajopen.ca/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fcmajo%2F11%2F1%2FE152.atom) 40. Mude W, Oguoma VM, Nyanhanda T, et al. (2021) Racial disparities in COVID-19 pandemic cases, hospitalisations, and deaths: a systematic review and meta-analysis. J Glob Health 11:05015. 41. Mackey K, Ayers CK, Kondo KK, et al. (2021) racial and ethnic disparities in COVID-19-related infections, hospitalizations, and deaths. Ann Intern Med 174:362–73. [CrossRef](http://www.cmajopen.ca/lookup/external-ref?access_num=10.7326/m20-6306&link_type=DOI) [PubMed](http://www.cmajopen.ca/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fcmajo%2F11%2F1%2FE152.atom) 42. Héguy L, Garneau M, Goldberg MS, et al. (2008) Associations between grass and weed pollen and emergency department visits for asthma among children in Montreal. Environ Res 106:203–11. [PubMed](http://www.cmajopen.ca/lookup/external-ref?access_num=18093580&link_type=MED&atom=%2Fcmajo%2F11%2F1%2FE152.atom) 43. Yang CL, Hicks EA, Mitchell P, et al. (2021) Canadian Thoracic Society 2021 Guideline update: diagnosis and management of asthma in preschoolers, children and adults. Can J Respir Crit Care Sleep Med 5:348–61. * © 2023 CMA Impact Inc. or its licensors